Effects of a structured treatment algorithm on blood pressure goal rates in both stage 1 and stage 2 hypertension

Journal of Human Hypertension

Volumn 20, Issue 4, 2006, Pages 255-262

  Neutel, J M ^a   Smith, D H G ^b,c   Silfani, T N ^d   Lee, Y ^e   Weber, M A ^f  

^a Orange County Research Center   (United States)

^b Integrium   (United States)

^c Memorial Research Medical Clinic   (United States)

^d DAIICHI SANKYO INC   (United States)

^e FOREST RESEARCH INSTITUTE   (United States)

^f SUNY Downstate Medical Center   (United States)

Author keywords

Angiotensin receptor blocker; Antihypertensive therapy; Blood pressure goal rates; Calcium blocker; Olmesartan medoxomil; Thiazide diuretics

Indexed keywords

AMLODIPINE BESYLATE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; HYDROCHLOROTHIAZIDE; OLMESARTAN; PLACEBO;

ABSCESS; ADULT; AGED; ALGORITHM; ARTICLE; BACKACHE; BLOOD PRESSURE REGULATION; BRONCHITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPENDENT EDEMA; DIASTOLIC BLOOD PRESSURE; DISEASE CLASSIFICATION; DRUG DOSE REGIMEN; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; DYSPNEA; FATIGUE; FEMALE; HEART INFARCTION; HEART PALPITATION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; MACULOPAPULAR RASH; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; OPEN STUDY; PHARYNGITIS; RHINITIS; SOMNOLENCE; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; THORAX PAIN; UPPER RESPIRATORY TRACT INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; AMLODIPINE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DIURETICS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; IMIDAZOLES; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TETRAZOLES; TREATMENT OUTCOME;

EID: 33645089450     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001974     Document Type: Article

References (7)

1. World Health Report 2002. Reducing Risks, Promoting Healthy Life. World Health Organization: Geneva, Switzerland, 2002.
2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252.
3. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003; 290: 199-206.
4. Weber M, Basile J, Izzo Jr J, Oparil S. Roundtable discussion: Blood pressure goal attainment: Meeting the challenge of the JNC 7's blood pressure goals and the role of renin-angiotensin-aldosterone system blockade. J Clin Hypertens (Greenwich) 2004; 6: 699-705.
5. Neutel JM, Smith DH, Weber MA, Wang AC, Masonson HN. Use of an olmesartan medoxomil-based treatment algorithm for hypertension control. J Clin Hypertens (Greenwich) 2004; 6: 168-174.
6. Singer GM, Izhar M, Black HR. Goal-oriented hypertension management: translating clinical trials to practice. Hypertension 2002; 40: 464-469.
7. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413-2446.